Works by Kalff, Anna

Results: 26

Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies.

Published in:

Cancer Biology & Medicine, 2016, v. 13, n. 2, p. 215, doi. 10.20892/j.issn.2095-3941.2016.0025

By:

Hocking, Jay;
Mithraprabhu, Sridurga;
Kalff, Anna;
Spencer, Andrew

Publication type:

Article

Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00796-9

By:

Mithraprabhu, Sridurga;
Reynolds, John;
Turner, Rose;
Quach, Hang;
Horvath, Noemi;
Kerridge, Ian;
Kalff, Anna;
Bergin, Krystal;
Hocking, Jay;
Yuen, Flora;
Khong, Tiffany;
Durie, Brian M.;
Spencer, Andrew

Publication type:

Article

Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma.

Published in:

Leukemia & Lymphoma, 2024, v. 65, n. 12, p. 1789, doi. 10.1080/10428194.2024.2373331

By:

Dimopoulos, Meletios A.;
Migkou, Magdalini;
Bhutani, Manisha;
Ailawadhi, Sikander;
Kalff, Anna;
Walcott, Farzana L.;
Pore, Nabendu;
Brown, Miranda;
Wang, Fujun;
Cheng, Lily I.;
Kagiampakis, Ioannis;
Williams, Marna;
Kinneer, Krista;
Wu, Yuling;
Jiang, Yu;
Kubiak, Robert J.;
Zonder, Jeffrey A.;
Larsen, Jeremy;
Sirdesai, Shreerang;
Yee, Andrew J.

Publication type:

Article

Cereblon pathway biomarkers and immune profiles in patients with myeloma receiving post-ASCT lenalidomide maintenance (LEOPARD).

Published in:

Leukemia & Lymphoma, 2021, v. 62, n. 12, p. 2981, doi. 10.1080/10428194.2021.1948030

By:

Kalff, Anna;
Khong, Tiffany;
Ramachandran, Malarmathy;
Walker, Patricia;
Schwarer, Anthony;
Roberts, Andrew W.;
Campbell, Philip;
Filshie, Robin;
Norton, Sam;
Reynolds, John;
Young, Mary;
Pierceall, William;
Thakurta, Anjan;
Guo, Manman;
Oppermann, Udo;
Wang, Maria;
Ren, Yan;
Kennedy, Nola;
Parekh, Samir;
Spencer, Andrew

Publication type:

Article

Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study.

Published in:

Leukemia & Lymphoma, 2019, v. 60, n. 9, p. 2122, doi. 10.1080/10428194.2019.1579322

By:

Horvath, Noemi;
Spencer, Andrew;
Kenealy, Melita;
Joshua, Douglas;
Campbell, Philip J;
Lee, Je-Jung;
Hou, Jian;
Qiu, Lugui;
Kalff, Anna;
Khong, Tiffany;
Londhe, Anil;
Siggins, Sarah;
van Kooten Losio, Maximiliano;
Eisbacher, Michael;
Prince, H. Miles

Publication type:

Article

Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study).

Published in:

Leukemia & Lymphoma, 2019, v. 60, n. 9, p. 2143, doi. 10.1080/10428194.2019.1571201

By:

Kalff, Anna;
Khong, Tiffany;
Mithraprabhu, Sridurga;
Bergin, Krystal;
Reynolds, John;
Bowen, Kathryn M.;
Thakurta, Anjan;
Guzman, Roberto;
Wang, Maria;
Couto, Suzana;
Ren, Yan;
Spencer, Andrew

Publication type:

Article

DCEP as a bridge to ongoing therapies for advanced relapsed and/or refractory multiple myeloma.

Published in:

Leukemia & Lymphoma, 2018, v. 59, n. 12, p. 2842, doi. 10.1080/10428194.2018.1454595

By:

Yuen, Hiu Lam Agnes;
Low, Michael Sze Yuan;
Fedele, Pasquale;
Kalff, Anna;
Walker, Patricia;
Bergin, Krystal;
Coutsouvelis, John;
Grigoriadis, George;
Spencer, Andrew

Publication type:

Article

Lenalidomide in multiple myeloma: Current status and future potential.

Published in:

American Journal of Hematology, 2012, v. 87, n. 12, p. 1089, doi. 10.1002/ajh.23234

By:

Quach, Hang;
Kalff, Anna;
Spencer, Andrew

Publication type:

Article

Whole genome sequencing and the genetics of extramedullary disease in multiple myeloma.

Published in:

Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-024-01208-2

By:

Bingham, Nicholas;
Shah, Jaynish;
Wong, Daniel;
Lim, Sueh-li;
Bergin, Krystal;
Kalff, Anna;
Reale, Antonia;
Khong, Tiffany;
Mithraprabhu, Sridurga;
Spencer, Andrew

Publication type:

Article

P-055: Extracellular RNA: an emerging biomarker for therapeutic monitoring in multiple myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S68, doi. 10.1016/S2152-2650(21)02189-3

By:

Mithraprabhu, Sridurga;
Morley, Rachel;
Chen, Moashan;
Ramachandran, Malarmathy;
Choi, Kawa;
Kalff, Anna;
Bergin, Krystal;
Yuen, Flora;
Shortt, Jake;
Khong, Tiffany;
Reynolds, John;
Spencer, Andrew

Publication type:

Article

Utilisation of liquid biopsies in functional high-risk myeloma demonstrates a unique mutational pattern and extensive spatial heterogeneity.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e7, doi. 10.1016/j.clml.2019.09.010

By:

Spencer, Andrew;
choi, Kawa;
Gorniak, Malgorzata;
Quach, Hang;
Horvath, Noemi;
Kerridge, Ian;
Lee, Edwin;
Morris, Edward;
Yuen, Flora;
Kalff, Anna;
Bergin, Krystal;
Khong, Tiffany;
Mithraprabhu, Sridurga

Publication type:

Article

A sequential cohort study evaluating single‐agent KappaMab and KappaMab combined with lenalidomide and low‐dose dexamethasone in relapsed and/or refractory kappa light chain‐restricted multiple myeloma (AMaRC 01‐16).

Published in:

British Journal of Haematology, 2023, v. 202, n. 4, p. 801, doi. 10.1111/bjh.18955

By:

Spencer, Andrew;
Kalff, Anna;
Shortt, Jake;
Quach, Hang;
Wallington‐Gates, Craig;
Reynolds, John;
Walker, Patricia;
Harrison, Simon J.;
Dunn, Rosanne;
Wellard, Cameron

Publication type:

Article

The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma Australia.

Published in:

Internal Medicine Journal, 2023, v. 53, n. 5, p. 819, doi. 10.1111/imj.16049

By:

Sim, Shirlene;
Kalff, Anna;
Tuch, Gina;
Mollee, Peter;
Ho, P. Joy;
Harrison, Simon;
Gibbs, Simon;
Prince, H. Miles;
Spencer, Andrew;
Joshua, Douglas;
Lee, Cindy;
Ling, Silvia;
Murphy, Nick;
Szabo, Ferenc;
Szer, Jeff;
Weber, Nicholas;
Ward, Christopher;
Talaulikar, Dipti;
Zannettino, Andrew;
Quach, Hang

Publication type:

Article

Upfront tandem autologous non‐myeloablative allogeneic stem cell transplant in high‐risk multiple myeloma: a long‐term single‐centre experience.

Published in:

Internal Medicine Journal, 2022, v. 52, n. 7, p. 1263, doi. 10.1111/imj.15842

By:

Nguyen, Phillip C.;
Muirhead, Jenny;
Tan, Joanne;
Kalff, Anna;
Bergin, Krystal;
Walker, Patricia;
Spencer, Andrew

Publication type:

Article

SARS‐CoV‐2 infection in autologous stem cell transplantation.

Published in:

Internal Medicine Journal, 2021, v. 51, n. 8, p. 1352, doi. 10.1111/imj.15255

By:

Wiltshire, Kaitlyn;
Kalff, Anna;
Morrissey, Catherine O.;
Griffin, David;
Patil, Sushrut;
Spring, Stephanie;
Spencer, Andrew;
Kliman, David

Publication type:

Article

Bisphosphonate guidelines for treatment and prevention of myeloma bone disease.

Published in:

Internal Medicine Journal, 2017, v. 47, n. 8, p. 938, doi. 10.1111/imj.13502

By:

Lee, Oi Lin;
Horvath, Noemi;
Lee, Cindy;
Joshua, Doug;
Ho, Joy;
Szer, Jeff;
Quach, Hang;
Spencer, Andrew;
Harrison, Simon;
Mollee, Peter;
Roberts, Andrew W.;
Talaulikar, Dipti;
Brown, Ross;
Augustson, Bradley;
Ling, Silvia;
Jaksic, Wilfrid;
Gibson, John;
Kalff, Anna;
Johnston, Anna;
Kalro, Akash

Publication type:

Article

Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group.

Published in:

Internal Medicine Journal, 2017, v. 47, n. 1, p. 35, doi. 10.1111/imj.13311

By:

Talaulikar, Dipti;
Tam, Constantine S.;
Joshua, Douglas;
Ho, Joy Phoebe;
Szer, Jeff;
Quach, Hang;
Spencer, Andrew;
Harrison, Simon;
Mollee, Peter;
Roberts, Andrew W.;
Horvath, Noemi;
Lee, Cindy;
Zannettino, Andrew;
Brown, Ross;
Augustson, Bradley;
Jaksic, Wilfrid;
Gibson, John;
Kalff, Anna;
Johnston, Anna;
Trotman, Judith

Publication type:

Article

A Novel RUNX1 Genetic Variant Identified in a Young Male with Severe Osteoporosis.

Published in:

JBMR Plus, 2023, v. 7, n. 9, p. 1, doi. 10.1002/jbm4.10791

By:

Block, Tomasz J.;
Shore‐Lorenti, Cat;
Zebaze, Roger;
Kerr, Peter G.;
Kalff, Anna;
Perkins, Andrew Charles;
Ebeling, Peter R.;
Milat, Frances

Publication type:

Article

A phase II trial of continuous ixazomib, thalidomide and dexamethasone for relapsed and/or refractory multiple myeloma: the Australasian Myeloma Research Consortium (AMaRC) 16‐02 trial.

Published in:

British Journal of Haematology, 2021, v. 194, n. 3, p. 580, doi. 10.1111/bjh.17504

By:

Bergin, Krystal;
Yuen, Flora;
Wallington‐Beddoe, Craig;
Kalff, Anna;
Sirdesai, Shreerang;
Reynolds, John;
Spencer, Andrew

Publication type:

Article

Phase II trial of single‐agent panobinostat consolidation improves responses after sub‐optimal transplant outcomes in multiple myeloma.

Published in:

British Journal of Haematology, 2021, v. 193, n. 1, p. 160, doi. 10.1111/bjh.17080

By:

Mithraprabhu, Sridurga;
Kalff, Anna;
Gartlan, Kate H.;
Savvidou, Ioanna;
Khong, Tiffany;
Ramachandran, Malarmathy;
Cooke, Rachel E.;
Bowen, Kathryn;
Hill, Geoffrey R.;
Reynolds, John;
Spencer, Andrew

Publication type:

Article

Central nervous system multiple myeloma - potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains.

Published in:

British Journal of Haematology, 2013, v. 162, n. 3, p. 371, doi. 10.1111/bjh.12404

By:

Lee, Denise;
Kalff, Anna;
Low, Michael;
Gangatharan, Shane;
Ho, Prahlad;
Bajel, Ashish;
Ritchie, David;
Grigg, Andrew;
Spencer, Andrew

Publication type:

Article

The impact of a regular erythrocytapheresis programme on the acute and chronic complications of sickle cell disease in adults.

Published in:

British Journal of Haematology, 2010, v. 149, n. 5, p. 768, doi. 10.1111/j.1365-2141.2010.08150.x

By:

Kalff, Anna;
Dowsing, Claire;
Grigg, Andrew

Publication type:

Article

A 40-Year-Old Man With Persistent Febrile Neutropenia and Subsequent Rash.

Published in:

2020

By:

Meher-Homji, Zaal;
North, Daniel;
Stewart, James D;
Moir, Diana;
Kalff, Anna;
Fleming, Shaun;
Ananda-Rajah, Michelle R;
Fuller, Andrew;
Morrissey, C Orla

Publication type:

Case Study

Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma.

Published in:

Epigenetics, 2014, v. 9, n. 11, p. 1511, doi. 10.4161/15592294.2014.983367

By:

Mithraprabhu, Sridurga;
Kalff, Anna;
Chow, Annie;
Khong, Tiffany;
Spencer, Andrew

Publication type:

Article

The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.820605

By:

Turner, Rose;
Kalff, Anna;
Bergin, Krystal;
Gorniak, Malgorzata;
Fleming, Shaun;
Spencer, Andrew

Publication type:

Article

B-acute leukemic lymphoblasts versus hematogones: the wolf in sheep's clothing/.

Published in:

Leukemia & Lymphoma, 2009, v. 50, n. 4, p. 523, doi. 10.1080/10428190902725839

By:

Kalff, Anna;
Juneja, Surender

Publication type:

Article